Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: alpelisib|DRUG: buparlisib|DRUG: Placebo
Sponsor: Novartis Pharmaceuticals